Charles D. Meyers

1.1k total citations
25 papers, 812 citations indexed

About

Charles D. Meyers is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Charles D. Meyers has authored 25 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Charles D. Meyers's work include Lipid metabolism and biosynthesis (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (6 papers). Charles D. Meyers is often cited by papers focused on Lipid metabolism and biosynthesis (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Lipid metabolism and disorders (6 papers). Charles D. Meyers collaborates with scholars based in United States, Switzerland and Russia. Charles D. Meyers's co-authors include Moti L. Kashyap, Karine Tremblay, Daniel Gaudet, Ahmed Amer, Jin Chen, Liewen Jiang, John D. Brunzell, Molly C. Carr, Sang Gyu Park and Vaijinath S. Kamanna and has published in prestigious journals such as Annals of Internal Medicine, Diabetes and The American Journal of Cardiology.

In The Last Decade

Charles D. Meyers

25 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles D. Meyers United States 16 375 296 240 159 125 25 812
Felicia Y. T. Yap Australia 12 495 1.3× 266 0.9× 209 0.9× 102 0.6× 148 1.2× 15 1.0k
Katsuya Yamazaki Japan 18 471 1.3× 197 0.7× 248 1.0× 162 1.0× 276 2.2× 49 1.2k
Camilla Pramfalk Sweden 19 319 0.9× 312 1.1× 276 1.1× 87 0.5× 316 2.5× 35 907
Anna Wolska United States 16 437 1.2× 407 1.4× 167 0.7× 278 1.7× 119 1.0× 61 913
Mengyin Cai China 15 409 1.1× 284 1.0× 399 1.7× 60 0.4× 199 1.6× 43 1.1k
Shahida Shafi United Kingdom 14 139 0.4× 193 0.7× 325 1.4× 198 1.2× 57 0.5× 29 808
Panai Song China 14 353 0.9× 279 0.9× 372 1.6× 66 0.4× 114 0.9× 27 904
S. Martini Italy 14 297 0.8× 449 1.5× 162 0.7× 167 1.1× 122 1.0× 27 912
Denise Drazul‐Schrader United States 8 307 0.8× 370 1.3× 255 1.1× 115 0.7× 74 0.6× 9 722
Sara Lombardi Italy 15 281 0.7× 91 0.3× 320 1.3× 153 1.0× 160 1.3× 30 1.1k

Countries citing papers authored by Charles D. Meyers

Since Specialization
Citations

This map shows the geographic impact of Charles D. Meyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Meyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Meyers more than expected).

Fields of papers citing papers by Charles D. Meyers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Meyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Meyers. The network helps show where Charles D. Meyers may publish in the future.

Co-authorship network of co-authors of Charles D. Meyers

This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Meyers. A scholar is included among the top collaborators of Charles D. Meyers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Meyers. Charles D. Meyers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yanling, William G. Haynes, Charles D. Meyers, et al.. (2019). The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes. Diabetes Obesity and Metabolism. 21(6). 1311–1321. 65 indexed citations
2.
Haynes, William G., Charles D. Meyers, Anisha E. Mendonza, et al.. (2018). LIK066, a Dual SGLT1/2 Inhibitor, Reduces Weight and Improves Multiple Incretin Hormones in Clinical Proof-of-Concept Studies in Obese Patients With or Without Diabetes. Diabetes. 67(Supplement_1). 3 indexed citations
3.
Roubenoff, Ronenn, Marcus Hompesch, Linda Morrow, et al.. (2017). Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals. Diabetes Obesity and Metabolism. 20(1). 94–102. 65 indexed citations
4.
Chen, Jin, et al.. (2017). Clinical Pharmacokinetics of Pradigastat, a Novel Diacylglycerol Acyltransferase 1 Inhibitor. 1 indexed citations
5.
Chen, Jin, Charles D. Meyers, Kenneth Kulmatycki, et al.. (2016). Pradigastat disposition in humans:in vivoandin vitroinvestigations. Xenobiotica. 47(12). 1077–1089. 4 indexed citations
6.
Gane, Edward, Catherine Stedman, Kiran Dole, et al.. (2016). A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial. ACS Infectious Diseases. 3(2). 144–151. 9 indexed citations
7.
Meyers, Charles D., Karine Tremblay, Ahmed Amer, et al.. (2015). Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome. Lipids in Health and Disease. 14(1). 8–8. 83 indexed citations
8.
Chen, Jin, Suraj G. Bhansali, Tapan Majumdar, et al.. (2015). Effect of pradigastat, a diacylglycerol acyltransferase 1 inhibitor, on the pharmacokinetics of a combination oral contraceptive in healthy female subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(4). 317–24. 1 indexed citations
9.
Gaudet, Daniel, James Signorovitch, Elyse Swallow, et al.. (2013). Medical resource use and costs associated with chylomicronemia. Journal of Medical Economics. 16(5). 657–666. 21 indexed citations
10.
Meyers, Charles D., Michael H. Serrano‐Wu, Ahmed Amer, et al.. (2013). The DGAT1 inhibitor Pradigastat Decreases Chylomicron Secretion and Prevents Postprandial Triglyceride Elevation in Humans. Journal of clinical lipidology. 7(3). 285–285. 21 indexed citations
11.
Meyers, Charles D., Madeline McCarren, Nathan D. Wong, et al.. (2006). Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial). The American Journal of Cardiology. 98(1). 63–65. 16 indexed citations
12.
Meyers, Charles D., Paul Liu, Vaijinath S. Kamanna, & Moti L. Kashyap. (2006). Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush. Atherosclerosis. 192(2). 253–258. 47 indexed citations
13.
Meyers, Charles D. & Moti L. Kashyap. (2005). Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies. Current Opinion in Internal Medicine. 4(5). 517–522. 23 indexed citations
14.
Meyers, Charles D., et al.. (2005). Niacin therapy in atherosclerosis. Current Opinion in Internal Medicine. 4(1). 20–26. 120 indexed citations
15.
Meyers, Charles D., et al.. (2004). Niacin therapy in atherosclerosis. Current Opinion in Lipidology. 15(6). 659–665. 129 indexed citations
16.
Meyers, Charles D. & Moti L. Kashyap. (2004). Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection. Current Opinion in Cardiology. 19(4). 366–373. 41 indexed citations
17.
Meyers, Charles D. & Moti L. Kashyap. (2004). Management of the metabolic syndrome—nicotinic acid. Endocrinology and Metabolism Clinics of North America. 33(3). 557–575. 17 indexed citations
18.
Meyers, Charles D., Lisa R. Tannock, Thomas N. Wight, & Alan Chait. (2003). Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL. Journal of Lipid Research. 44(11). 2152–2160. 21 indexed citations
19.
Meyers, Charles D., Molly C. Carr, Sang Gyu Park, & John D. Brunzell. (2003). Varying Cost and Free Nicotinic Acid Content in Over-the-Counter Niacin Preparations for Dyslipidemia. Annals of Internal Medicine. 139(12). 996–1002. 54 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felicia Y. T. Yap Breakdown of academic impact, for papers by Katsuya Yamazaki Breakdown of academic impact, for papers by Camilla Pramfalk Breakdown of academic impact, for papers by Anna Wolska Breakdown of academic impact, for papers by Mengyin Cai Breakdown of academic impact, for papers by Shahida Shafi Breakdown of academic impact, for papers by Panai Song Breakdown of academic impact, for papers by S. Martini Breakdown of academic impact, for papers by Denise Drazul‐Schrader Breakdown of academic impact, for papers by Sara Lombardi
Rankless by CCL
2026